🌐 Zolgensma
Zolgensma is a gene therapy brand developed by Novartis that may be monitored globally for regulatory decisions, market access, safety updates, and commercial activity.
5
Signals
8
Articles
Linked Signals
| Signal | Status | Lens | Role | Confidence | Last Seen |
|---|---|---|---|---|---|
| Nautical Institute UAE Branch puts seafarer welfare centre stage at Marine Ball 2026 | active | Health | responder | 100% | |
| Johnson & Johnson wins FDA approval for Rybrevant cancer treatment | active | Health | involved | 100% | |
| Joey Logano reveals health status after major flip at Talladega | expired | Health | responder | 100% | |
| Arthur Fils says if he feels confident of playing the Paris Masters after retiring injured in Basel | expired | Health | responder | 68% | |
| Novartis reveals cancer cases possibly linked to gene therapy Zolgensma | active | AI & Tech | involved | 66% |